Global OTC Consumer Healthcare 麻豆原创 Research Report 2023

Publication ID:

PB502236334

Publication Date:

February 28, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global OTC Consumer Healthcare market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for OTC Consumer Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for OTC Consumer Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for OTC Consumer Healthcare in Pharmacy or Drug Stores is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of OTC Consumer Healthcare include Sun Pharmaceutical Industries, Glenmark Pharmaceuticals, Johnson & Johnson, Pfizer, American Health, Abbott Laboratories, GlaxoSmithKline, Sanofi and Piramal Enterprises, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Consumer Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Consumer Healthcare.
The OTC Consumer Healthcare market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OTC Consumer Healthcare market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Consumer Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sun Pharmaceutical Industries
Glenmark Pharmaceuticals
Johnson & Johnson
Pfizer
American Health
Abbott Laboratories
GlaxoSmithKline
Sanofi
Piramal Enterprises
Boehringer Ingelheim
Bayer
Teva Pharmaceutical Industries
Ipsen SA
Koninklijke DSM
Reckitt Benckiser
Lonza Group
Segment by Type
OTC Pharmaceuticals
Dietary Supplement
Segment by Application
Pharmacy or Drug Stores
Specialty Stores
Online Retailers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Consumer Healthcare companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global OTC Consumer Healthcare 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 OTC Pharmaceuticals
1.2.3 Dietary Supplement
1.3 麻豆原创 by Application
1.3.1 Global OTC Consumer Healthcare 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmacy or Drug Stores
1.3.3 Specialty Stores
1.3.4 Online Retailers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Consumer Healthcare 麻豆原创 Perspective (2018-2029)
2.2 OTC Consumer Healthcare Growth Trends by Region
2.2.1 Global OTC Consumer Healthcare 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Consumer Healthcare Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 OTC Consumer Healthcare Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 OTC Consumer Healthcare 麻豆原创 Dynamics
2.3.1 OTC Consumer Healthcare Industry Trends
2.3.2 OTC Consumer Healthcare 麻豆原创 Drivers
2.3.3 OTC Consumer Healthcare 麻豆原创 Challenges
2.3.4 OTC Consumer Healthcare 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Consumer Healthcare Players by Revenue
3.1.1 Global Top OTC Consumer Healthcare Players by Revenue (2018-2023)
3.1.2 Global OTC Consumer Healthcare Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global OTC Consumer Healthcare 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Consumer Healthcare Revenue
3.4 Global OTC Consumer Healthcare 麻豆原创 Concentration Ratio
3.4.1 Global OTC Consumer Healthcare 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Consumer Healthcare Revenue in 2022
3.5 OTC Consumer Healthcare Key Players Head office and Area Served
3.6 Key Players OTC Consumer Healthcare Product Solution and Service
3.7 Date of Enter into OTC Consumer Healthcare 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Consumer Healthcare Breakdown Data by Type
4.1 Global OTC Consumer Healthcare Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global OTC Consumer Healthcare Forecasted 麻豆原创 Size by Type (2024-2029)
5 OTC Consumer Healthcare Breakdown Data by Application
5.1 Global OTC Consumer Healthcare Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global OTC Consumer Healthcare Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America OTC Consumer Healthcare 麻豆原创 Size (2018-2029)
6.2 North America OTC Consumer Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Consumer Healthcare 麻豆原创 Size by Country (2018-2023)
6.4 North America OTC Consumer Healthcare 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Consumer Healthcare 麻豆原创 Size (2018-2029)
7.2 Europe OTC Consumer Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Consumer Healthcare 麻豆原创 Size by Country (2018-2023)
7.4 Europe OTC Consumer Healthcare 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Consumer Healthcare 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific OTC Consumer Healthcare 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Consumer Healthcare 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific OTC Consumer Healthcare 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Consumer Healthcare 麻豆原创 Size (2018-2029)
9.2 Latin America OTC Consumer Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Consumer Healthcare 麻豆原创 Size by Country (2018-2023)
9.4 Latin America OTC Consumer Healthcare 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Consumer Healthcare 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa OTC Consumer Healthcare 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Consumer Healthcare 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa OTC Consumer Healthcare 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sun Pharmaceutical Industries
11.1.1 Sun Pharmaceutical Industries Company Detail
11.1.2 Sun Pharmaceutical Industries Business Overview
11.1.3 Sun Pharmaceutical Industries OTC Consumer Healthcare Introduction
11.1.4 Sun Pharmaceutical Industries Revenue in OTC Consumer Healthcare Business (2018-2023)
11.1.5 Sun Pharmaceutical Industries Recent Development
11.2 Glenmark Pharmaceuticals
11.2.1 Glenmark Pharmaceuticals Company Detail
11.2.2 Glenmark Pharmaceuticals Business Overview
11.2.3 Glenmark Pharmaceuticals OTC Consumer Healthcare Introduction
11.2.4 Glenmark Pharmaceuticals Revenue in OTC Consumer Healthcare Business (2018-2023)
11.2.5 Glenmark Pharmaceuticals Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson OTC Consumer Healthcare Introduction
11.3.4 Johnson & Johnson Revenue in OTC Consumer Healthcare Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer OTC Consumer Healthcare Introduction
11.4.4 Pfizer Revenue in OTC Consumer Healthcare Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 American Health
11.5.1 American Health Company Detail
11.5.2 American Health Business Overview
11.5.3 American Health OTC Consumer Healthcare Introduction
11.5.4 American Health Revenue in OTC Consumer Healthcare Business (2018-2023)
11.5.5 American Health Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories OTC Consumer Healthcare Introduction
11.6.4 Abbott Laboratories Revenue in OTC Consumer Healthcare Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline OTC Consumer Healthcare Introduction
11.7.4 GlaxoSmithKline Revenue in OTC Consumer Healthcare Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi OTC Consumer Healthcare Introduction
11.8.4 Sanofi Revenue in OTC Consumer Healthcare Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Piramal Enterprises
11.9.1 Piramal Enterprises Company Detail
11.9.2 Piramal Enterprises Business Overview
11.9.3 Piramal Enterprises OTC Consumer Healthcare Introduction
11.9.4 Piramal Enterprises Revenue in OTC Consumer Healthcare Business (2018-2023)
11.9.5 Piramal Enterprises Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Detail
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim OTC Consumer Healthcare Introduction
11.10.4 Boehringer Ingelheim Revenue in OTC Consumer Healthcare Business (2018-2023)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Bayer
11.11.1 Bayer Company Detail
11.11.2 Bayer Business Overview
11.11.3 Bayer OTC Consumer Healthcare Introduction
11.11.4 Bayer Revenue in OTC Consumer Healthcare Business (2018-2023)
11.11.5 Bayer Recent Development
11.12 Teva Pharmaceutical Industries
11.12.1 Teva Pharmaceutical Industries Company Detail
11.12.2 Teva Pharmaceutical Industries Business Overview
11.12.3 Teva Pharmaceutical Industries OTC Consumer Healthcare Introduction
11.12.4 Teva Pharmaceutical Industries Revenue in OTC Consumer Healthcare Business (2018-2023)
11.12.5 Teva Pharmaceutical Industries Recent Development
11.13 Ipsen SA
11.13.1 Ipsen SA Company Detail
11.13.2 Ipsen SA Business Overview
11.13.3 Ipsen SA OTC Consumer Healthcare Introduction
11.13.4 Ipsen SA Revenue in OTC Consumer Healthcare Business (2018-2023)
11.13.5 Ipsen SA Recent Development
11.14 Koninklijke DSM
11.14.1 Koninklijke DSM Company Detail
11.14.2 Koninklijke DSM Business Overview
11.14.3 Koninklijke DSM OTC Consumer Healthcare Introduction
11.14.4 Koninklijke DSM Revenue in OTC Consumer Healthcare Business (2018-2023)
11.14.5 Koninklijke DSM Recent Development
11.15 Reckitt Benckiser
11.15.1 Reckitt Benckiser Company Detail
11.15.2 Reckitt Benckiser Business Overview
11.15.3 Reckitt Benckiser OTC Consumer Healthcare Introduction
11.15.4 Reckitt Benckiser Revenue in OTC Consumer Healthcare Business (2018-2023)
11.15.5 Reckitt Benckiser Recent Development
11.16 Lonza Group
11.16.1 Lonza Group Company Detail
11.16.2 Lonza Group Business Overview
11.16.3 Lonza Group OTC Consumer Healthcare Introduction
11.16.4 Lonza Group Revenue in OTC Consumer Healthcare Business (2018-2023)
11.16.5 Lonza Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Sun Pharmaceutical Industries
Glenmark Pharmaceuticals
Johnson & Johnson
Pfizer
American Health
Abbott Laboratories
GlaxoSmithKline
Sanofi
Piramal Enterprises
Boehringer Ingelheim
Bayer
Teva Pharmaceutical Industries
Ipsen SA
Koninklijke DSM
Reckitt Benckiser
Lonza Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.